Lucas Poncelet, Keith Morton, Matthew Shiu, Gaétan Veilleux, Chantal Richer, Liviu Clime, Daniel Sinnett, Teodor Veres
for use in cancer patient risk stratification. The system presented herein represents a significant advancement in exosome purification, offering a robust and automated platform for liquid biopsy-based cancer research and clinical applications. This innovation holds promise for cancer diagnosis, prognosis, and monitoring through non-invasive biomarkers.